IP Library Assignment 059855/0252
Patent Assignment
Reel/Frame 059855/0252

Corrective Assignment to Correct the Removal of Application Numbers 12866448 and Aplication Number 14292481 Previously Recorded at Reel: 059790 Frame: 0722. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2022-05-04 Pages: 5
Assignor
IMPEL NEUROPHARMA, INC.
Executed: 2022-04-15
Assignee
IMPEL PHARMACEUTICALS INC.
201 ELLIOTT AVENUE, WEST, SUITE 260, SEATTLE, WASHINGTON, 98119
Covered Properties (24)
Intranasal Device with Dip Tube
Application: 16/198,403 →
Publication: US 2019/0151579
Intranasal Device with Inlet Interface
Application: 16/198,312 →
Publication: US 2019/0151576
Respiratory Tract Delivery of Levodopa and Dopa Decarboxylase Inhibitor for Treatment of Parkinson's Disease
Application: 16/517,423 →
Publication: US 2020/0046667
Nasal Drug Delivery Device with Detachable Nozzle
Application: 17/420,640 →
Publication: US 2022/0088327
Single-Use Nasal Delivery Device
Application: 16/875,906 →
Publication: US 2020/0360627
Nasal Drug Delivery Device
Application: 16/664,588 →
Publication: US 2020/0078544
Repeated Administration of Dihydroergotamine for Treatment of Frequent Migraine Headaches
Application: 17/148,154 →
Publication: US 2021/0236485
Nozzles for Nasal Drug Delivery
Application: 17/164,371 →
Publication: US 2021/0322689
Respiratory Tract Delivery of Levodopa and Dopa Decarboxylase Inhibitor for Treatment of Parkinson's Disease
Application: 17/682,033 →
Publication: US 2022/0233486
Intranasal Delivery of Levodopa Powder by Precision Olfactory Device
Application: 17/498,381 →
Publication: US 2022/0296504
Intranasal Delivery of Dihydroergotamine by Precision Olfactory Device
Application: 17/492,136 →
Publication: US 2022/0105030
Intranasal Delivery of Olanzapine by Precision Olfactory Device
Application: 17/574,511 →
Publication: US 2022/0183965
In-line Nasal Delivery Device
Application: 17/585,099 →
Nasal Drug Delivery Device
Patent: 9,550,036 →
Application: 14/017,048 →
Publication: US 2014/0014104
Nasal Drug Delivery Device
Application: 15/338,097 →
Publication: US 2017/0043109
Nozzles for Nasal Drug Delivery
Patent: 9,919,117 →
Application: 14/075,126 →
Publication: US 2014/0083424
Medical Unit Dose Container
Application: 14/787,455 →
Publication: US 2016/0101245
In-line Nasal Delivery Device
Application: 15/759,447 →
Publication: US 2018/0256836
Nozzles for Nasal Drug Delivery
Application: 15/844,474 →
Publication: US 2018/0126101
Intranasal Delivery of Olanzapine by Precision Olfactory Device
Application: 16/240,653 →
Publication: US 2019/0240150
Nozzles for Nasal Drug Delivery
Application: 15/890,266 →
Publication: US 2018/0236190
Medical Unit Dose Container
Application: 16/695,147 →
Publication: US 2020/0101243
Intranasal Delivery of Dihydroergotamine by Precision Olfactory Device
Application: 17/062,364 →
Publication: US 2021/0022995
Repeated Administration of Dihydroergotamine for Treatment of Frequent Migraine Headaches
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 8, 2013
From: HOEKMAN, JOHN D.; HITE, MICHAEL; BRUNELLE, ALAN; RELETHFORD, JOEL
To: IMPEL NEUROPHARMA INC.
Reel/Frame 031568/0088 →
Assignment of Assignor's Interest Oct 27, 2015
From: HOEKMAN, JOHN D.; KOHRING, CRAIG; FULLER, CHRISTOPHER; BRUNELLE, ALAN
To: IMPEL NEUROPHARMA INC.
Reel/Frame 036896/0759 →
Assignment of Assignor's Interest Jun 29, 2016
From: HOEKMAN, JOHN D.; HO, RODNEY J.Y.
To: IMPEL NEUROPHARMA INC.
Reel/Frame 039208/0553 →
Assignment of Assignor's Interest Jun 29, 2016
From: HOEKMAN, JOHN D.; BRUNELLE, ALAN; RELETHFORD, JOEL; HITE, MICHAEL
To: IMPEL NEUROPHARMA INC.
Reel/Frame 039046/0787 →
Assignment of Assignor's Interest Jun 29, 2016
From: HOEKMAN, JOHN D.; BRUNELLE, ALAN; HITE, MICHAEL; RELETHFORD, JOEL
To: IMPEL NEUROPHARMA INC.
Reel/Frame 039046/0898 →
Assignment of Assignor's Interest Jun 29, 2016
From: HOEKMAN, JOHN D.; RELETHFORD, JOEL; HO, RODNEY J.Y.; HITE, MICHAEL
To: IMPEL NEUROPHARMA INC.
Reel/Frame 039046/0971 →
Corrective Assignment to Correct the Assignment Document to Insert the Serial Number and Filing Date of the Subject Application Previously Recorded on Reel 036896 Frame 0759. Assignor(S) Hereby Confirms the Assignment. Mar 13, 2018
From: HOEKMAN, JOHN D.; KOHRING, CRAIG; FULLER, CHRISTOPHER; BRUNELLE, ALAN
To: IMPEL NEUROPHARMA INC.
Reel/Frame 045583/0575 →
Assignment of Assignor's Interest May 22, 2018
From: HOEKMAN, JOHN D.; HITE, MICHAEL; BRUNELLE, ALAN; RELETHFORD, JOEL
To: IMPEL NEUROPHARMA INC.
Reel/Frame 045866/0265 →
Assignment of Assignor's Interest Jun 21, 2018
From: HOEKMAN, JOHN D.; FULLER, CHRISTOPHER; KOHRING, CRAIG
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 046167/0700 →
Assignment of Assignor's Interest Jun 22, 2018
From: HOEKMAN, JOHN D.; HITE, MICHAEL; BRUNELLE, ALAN; RELETHFORD, JOEL
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 046182/0959 →
Assignment of Assignor's Interest Jul 1, 2018
From: HOEKMAN, JOHN D.; HITE, MICHAEL; BRUNELLE, ALAN; RELEFORD, JOEL
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 046247/0810 →
Assignment of Assignor's Interest Apr 2, 2019
From: KOHRING, CRAIG FREDERICK; FULLER, CHRISTOPHER WILLIAM
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 048775/0370 →
Assignment of Assignor's Interest Apr 2, 2019
From: KOHRING, CRAIG FREDERICK; FULLER, CHRISTOPHER WILLIAM
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 048774/0648 →
Assignment of Assignor's Interest Nov 8, 2019
From: HOEKMAN, JOHN D.; HITE, MICHAEL; BRUNELLE, ALAN; RELETHFORD, JOEL
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 050961/0234 →
Assignment of Assignor's Interest May 6, 2020
From: HOEKMAN, JOHN D.; SATTERLY, KELSEY H.; DASHEVSKY, INNA; SHREWSBURY, STEPHEN B.
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 052593/0891 →
Assignment of Assignor's Interest May 6, 2020
From: DAS, ADITYA R.
To: PHARMACEUTICAL CONSULTING LLC
Reel/Frame 052595/0337 →
Assignment of Assignor's Interest Aug 12, 2020
From: HOEKMAN, JOHN D.; LAVIN, ALBERT KENNETH; FULLER, CHRISTOPHER WILLIAM; KOHRING, CRAIG FREDERICK
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 053470/0078 →
Assignment of Assignor's Interest Oct 22, 2020
From: PHARMACEUTICAL CONSULTING LLC
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 054142/0603 →
Security Interest Nov 5, 2020
From: IMPEL NEUROPHARMA, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
Reel/Frame 054287/0473 →
Assignment of Assignor's Interest Feb 4, 2021
From: HOEKMAN, JOHN D.; HITE, MICHAEL; BRUNELLE, ALAN; RELETHFORD, JOEL
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 055148/0790 →
Assignment of Assignor's Interest Mar 29, 2021
From: HOEKMAN, JOHN D.; SATTERLY, KELSEY H.; SHREWSBURY, STEPHEN B.; YOUMANS, SCOTT
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 055744/0936 →
Assignment of Assignor's Interest Jul 2, 2021
From: FULLER, CHRISTOPHER WILLIAM; KOHRING, CRAIG FREDERICK; LAVIN, ALBERT KENNETH; HOEKMAN, JOHN D.
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 056748/0747 →
Release of Security Interest Jul 6, 2021
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 056758/0495 →
Corrective Assignment to Correct the Patent Number and Grant Date Which Were Inadvertently Switched for Two Patents in Exhibit a of the Release of Security Interest Previously Recorded at Reel: 056758 Frame: 0495. Assignor(S) Hereby Confirms the Release of Security Interest. Sep 14, 2021
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: IMPEL NEUOPHARMA, INC.
Reel/Frame 057683/0200 →
Assignment of Assignor's Interest Oct 8, 2021
From: HOEKMAN, JOHN D.; SATTERLY, KELSEY H.; SHREWSBURY, STEPHEN B.; YOUMANS, SCOTT
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 057745/0482 →